When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EXEL - 1 Reason to Buy Exelixis Stock and 1 Reason to Sell
Exelixis Inc.
Biotech company Exelixis (NASDAQ: EXEL) is not the most famous name in the industry. But quietly, the oncology-focused drugmaker has provided excellent returns this year, even though it's been a bit of a roller-coaster ride.
If Exelixis can continue beating the market, investors would do well to purchase its shares now. But it's not a given that it will. Let's consider one reason the biotech could have a bright future -- and be an excellent investment -- and also why it may not be worth your hard-earned money.